"AI-accelerated research to define aging in the brain, enabling personalized therapies and faster market delivery for aging populations"

Errungenschaften

Team
SVG
Prototyp
SVG
Nutzer
SVG
Partner
SVG
Umsätze
SVG
Investoren
SVG

Unser Angebot

- New biomarkers and therapeutics for aging and psychiatric disorders.
- Diagnostics and drug candidates targeting glial cells.
- AI-powered research for personalized aging therapies.
- Strategic partnerships and IP licensing to the pharmaceutical industry.
- Diagnostic pipeline for stratifying aging and predicting clinical outcomes.

Zielgruppe

- Pharmaceutical companies
- Clinical research organizations
- Healthcare providers specializing in aging and neurodegenerative diseases
- Investors in biotech and AI-driven medical solutions
- Collaborative research partners in the medical and biotech fields

Herausforderungen

- Securing funding and investment.
- Building and maintaining strategic partnerships.
- Regulatory approvals for new diagnostics and therapeutics.
- Scaling operations efficiently.
- Protecting intellectual property and managing legal issues.

Unsere Story

I have been working in this area for nearly 15 years first in Academia before moving over to companies. I have seen the major gaps arise in the technologies we need to characterize aging in the brain since several years now and this is where I see an opportunity.